ArticleFrontiers in oncology2025
Prevalence of precancerous cervical lesions and associated factors among HIV-positive women in Zewditu Memorial Hospital, Addis Ababa, Ethiopia.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Cervical cancer is one of the major causes of morbidity and mortality among women in low- and middle-income countries. This problem is more severe in developing countries than in developed countries. This study was designed to identify the prevalence and determinants of precancerous cervical lesions among HIV-positive women in the Zewditu Memorial Hospital, Addis Ababa, Ethiopia. Objective: This study aimed to assess the prevalence of precancerous cervical lesions and associated factors among HIV-positive women in Zewditu Memorial Hospital, Addis Ababa, Ethiopia. Methods: An institution-based, cross-sectional, quantitative study was conducted. The sample size for the study was 361, which was calculated using a single population proportion method, and the final study participants were HIV-positive clients who were eligible for cervical cancer screening and selected using a simple random sampling method. Data were collected from each study participant using an interviewer-administered questionnaire. Data were then entered into Epi Info version 7, cleaned, and analyzed using SPSS version 25. Bivariable and multivariable logistic regression analyses were used to examine the relationship or statistical association between the independent and dependent variables, and odds ratios with 95% confidence intervals were computed. Results: A total of 361 women who had follow-ups at an antiretroviral therapy clinic were included in the study. The prevalence of precancerous cervical lesions was 16.6%. Having a history of sexually transmitted disease [adjusted odds ratio (AOR) = 4.88, 95% confidence interval (CI): 1.66-14.36, p-value = 0.004], a history of smoking (AOR = 9.35, 95% CI: 3.15-27.75, p-value = 0.000), and abortion (AOR = 3.23, 95% CI: 1.58-6.58, p-value = 0.001) were significantly associated with precancerous cervical lesions. Conclusion and recommendations: The prevalence of precancerous cervical lesions in this study was high. A history of abortion, smoking, and sexually transmitted infections were strongly associated with precancerous cervical lesions among women with human immunodeficiency virus. Hence, it is important to emphasize the importance of preventing sexually transmitted infections and repeated abortions, as well as discouraging cigarette smoking.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.